CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Prevea Health

Luke Mitchell, Executive Director - Ambulatory Surgery, Ortho, Podiatry

The Future of Outpatient Ambulatory Surgery: A Business and Site of Care Transformation

Luke Mitchell

Luke Mitchell

Through this article, Mitchell emphasizes the rapid shift of surgical procedures from traditional hospital settings to ambulatory surgery centers (ASCs), highlighting their cost efficiency and the technological advancements positioning ASCs as the future of modern surgical care.


The healthcare industry is undergoing a fundamental shift as surgical procedures continue transitioning from traditional inpatient settings to ambulatory surgery centers (ASCs). This site-of-care transformation is driven by rising healthcare costs, technological advancements and evolving payer incentives that favor outpatient settings. As healthcare leaders search for innovative ways to improve efficiency and affordability, ASCs have emerged as a critical solution in modern surgical care.


Today, there are more than 6,000 ASCs across the United States, performing over 23 million procedures annually (MedPAC, 2023). These centers are not only reshaping how surgery is delivered but also expanding their capabilities to include more complex procedures, such as total joint replacements, spine surgeries and select cardiovascular interventions. With continued advances in surgical techniques, anesthesia and digital health, ASCs are positioned to become the dominant setting for many procedures traditionally performed in hospitals. The question is no longer whether outpatient surgery will continue growing, but rather how fast and how far the shift will go.


The Evolution of Outpatient Surgery


The concept of ambulatory surgery dates to the 1970s when physicians sought a more efficient and cost-effective alternative to hospital-based procedures. Over the decades, improvements in anesthesia, minimally invasive techniques and enhanced recovery protocols have allowed more procedures to be performed safely in outpatient settings (ASCA, 2023).


Initially, ASCs focused on low-acuity procedures, such as cataract surgeries and endoscopies. However, recent policy changes have enabled a broader range of surgeries to shift to ASCs. The Centers for Medicare & Medicaid Services (CMS) has expanded its list of ASC-approved procedures, including total knee arthroplasty, cardiac catheterization and select spine surgeries (CMS, 2024). These changes signal a growing recognition of ASCs’ ability to provide high-quality, cost-effective surgical care.


ASCs typically perform procedures at 30 to 50 percent lower costs than hospital outpatient departments (HOPDs), primarily due to lower facility fees, streamlined workflows and reduced administrative burdens.


The increasing shift of surgeries from hospital operating rooms to ASCs is driven by multiple factors. Patients are seeking more convenient and affordable options, insurers are incentivizing cost-effective care settings and surgeons are looking for more control over their practice environments. The alignment of these interests has fueled the rapid expansion of ASCs and their role in the healthcare ecosystem.


The Business Case for ASCs


One of the most compelling reasons for the growth of ASCs is their cost efficiency. ASCs typically perform procedures at 30 to 50 percent lower costs than hospital outpatient departments (HOPDs), primarily due to lower facility fees, streamlined workflows and reduced administrative burdens (Health Affairs, 2022). These savings benefit not only payers and employers but also patients, who experience lower outof-pocket expenses.


Despite the cost advantages, ASCs have faced reimbursement challenges. Historically, CMS and private insurers have reimbursed ASCs at lower rates than hospital outpatient departments for the same procedures. Currently, ASCs receive approximately 80 percent of the reimbursement that hospitals receive for identical services (MedPAC, 2023). While policymakers are beginning to recognize the value that ASCs bring to the healthcare system, reimbursement disparities remain an ongoing concern.


Payer strategies are also evolving in ways that favor ASCs. Direct-to-employer contracts and bundled payment arrangements are gaining popularity as employers seek to control healthcare costs. By steering employees toward ASCs for procedures such as joint replacements and colonoscopies, employers can reduce expenses while maintaining high-quality care (KFF, 2023).


Expanding Surgical Specialties in ASCs


The range of procedures performed in ASCs continues to expand. Total joint replacements have become one of the fastest-growing areas in outpatient surgery, with a more than 200 percent increase in ASC-based procedures over the past five years (AAOS, 2023). Advances in minimally invasive techniques, improved pain management protocols and enhanced recovery after surgery (ERAS) programs have made it possible for patients to undergo joint replacements and return home the same day.


Spine surgery is another area experiencing significant growth in ASCs. Minimally invasive spine procedures, including microdiscectomies and fusions, are increasingly being performed in outpatient settings. The ability to manage post-operative pain effectively has been a key factor in this shift, allowing patients to recover in the comfort of their homes rather than spending extended time in hospitals (Becker’s ASC Review, 2023).


The cardiology field is also beginning to embrace outpatient surgery. With CMS now approving select cardiac procedures for ASCs, including percutaneous coronary interventions (PCI) and pacemaker placements, the potential for expansion in this specialty is substantial (CMS, 2024). As technology advances and reimbursement policies continue to evolve, cardiovascular interventions are likely to become a larger part of ASC services.


Technology and Innovation Driving ASC Growth


Technological advancements are playing a crucial role in the transformation of outpatient surgery. Robotics and minimally invasive surgical techniques are now being integrated into ASCs, improving precision, reducing recovery times and enhancing patient outcomes. While robotic-assisted surgery was once confined to large hospitals, it is increasingly being adopted in ASCs, particularly in orthopedic and spine procedures (Becker’s ASC Review, 2023).


Digital health solutions are also contributing to the growth of ASCs. Telehealth and remote patient monitoring are improving preoperative assessments and postoperative care, reducing complications and enhancing patient engagement. Wearable technology allows surgeons to track recovery metrics in real time, enabling early intervention if complications arise (Health Affairs, 2022).


Artificial intelligence (AI) is also beginning to shape decision-making in ASCs. AI-driven analytics help optimize patient selection, predict surgical risks and improve operating room efficiency. Machine learning algorithms are also being used to refine scheduling processes, reducing downtime and increasing case volumes (AMA, 2023).


The business of outpatient ambulatory surgery is at a critical inflection point. ASCs have proven their value in delivering efficient, high-quality and cost-effective care, and their role will only continue to grow. However, addressing challenges related to reimbursement, staffing and regulation will be essential to ensuring their long-term success.


As the healthcare industry moves further toward value-based care, ASCs will become the cornerstone of modern surgical delivery. Their ability to provide high-quality outcomes at lower costs makes them not just a preferred alternative to hospitals, but the future of surgical care itself.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/the-future-of-outpatient-ambulatory-surgery-a-business-and-site-of-care-transformation-nwid-3015.html